🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 12-week, randomized, multicenter, double-blind, placebo controlle...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-02
Trial ID
NCT01000493
Treatments Being Tested
This study is being conducted to obtain information on the safety and toler...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06-12
Trial ID
NCT00511654
Treatments Being Tested
This is a 6-week, randomised, multicenter, double-blind, placebo controlled...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-03-01
Trial ID
NCT00880399
Treatments Being Tested
This is a single centre, open-label, non-randomised study to assess the mas...
Status
Completed
Location
Quotient Sciences
Start Date
2020-06-01
Trial ID
NCT04387981
Treatments Being Tested
This is a 6-week, randomised, multicenter, double-blind, placebo controlled...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-03-11
Trial ID
NCT00880048
Treatments Being Tested
The purpose of this study is to determine the effectiveness of three doses ...
Status
Completed
Location
Study Site 15
Start Date
2017-05-22
Trial ID
NCT02993822
Treatments Being Tested
The purpose of this study is to determine the effectiveness of three doses ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-05
Trial ID
NCT03464526
Treatments Being Tested
A Phase 1 study to assess the effect of itraconazole, a strong inhibitor of...
Status
Completed
Location
Parexel Epcu
Start Date
2018-06-08
Trial ID
NCT03535662
Treatments Being Tested
This study is an open-label, randomised, single dose study to determine the...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-08-28
Trial ID
NCT00843011
Treatments Being Tested
ORV-PF-01 is a two way, placebo controlled, cross-over study, to evaluate t...
Status
Completed
Location
University of Southern California
Start Date
2022-08-01
Trial ID
NCT05185089
Treatments Being Tested